Bryan Gilburg - China

“The TFDA has expressed interest in improving the advertisement review times by auto-approving ads for some low risk products.”

Noi Suwannabot

General Manager, Asia Actual Thailand

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sign Up For Our Newsletter to Stay Informed

Sign Up

Thailand FDA to Improve Medical Device Advertising Review Times

Published on: January 22nd, 2024

In a training seminar held on January 15 and 16, 2024, by the Thai FDA on the Full Common Submission Dossier Template (CSDT), the TFDA stated its intention to improve advertising review times. Per the Deputy Secretary General, they plan to implement new processes meant to help expedite the review and approval of advertisement applications. The proposed changes include auto-approving some Class 1 advertisement materials.

It’s important to note that these updates are not formal, and more information will be provided once official guidance and/or regulations are released. 

For more information on registering medical device advertisements in Thailand, please see our dedicated page on the topic here. 

Some Class 1 Product Advertisements May Receive Auto-Approval 

One of the significant updates is that the TFDA will begin auto-approving some Class 1 products to help clear out the application backlog. For example, the TFDA expressed the intention to auto-approve all products listed under Class 1, Rule 4 including the following product types: 

  • Hospital beds 
  • Wheelchairs 
  • Commode chairs 
  • Bath trollies 
  • Emergency trollies, medical equipment table/trolley 
  • Walking aids 
  • Overbed tables 
  • IV poles 
  • Examination beds 
  • Stairs 
  • Cabinets 
  • Stretchers 
  • Electric hospital beds 
  • Electric wheelchairs 
  • Baby weight scales 
  • Weighing scales with wheelchairs 

Asia Actual will monitor regulation updates from the TFDA and will provide updates as soon as they’re available.

Advertising Review Process

Currently, the advertising review process can be difficult and time consuming for some advertisers marketing direct to consumer. The TFDA closely reviews all advertisements to ensure the claims being made are accurate and proven.

Advertisements directed towards Healthcare Professionals (HCPs) do not need to be reviewed but do need to be submitted to an online portal prior to placing on the market.

More information on the medical device advertising requirements can be found here on our dedicated page.

Come Grow with Us

Please contact Asia Actual with any questions or requests for support in Thailand. We have offices staffed by experienced, bilingual regulatory and commercial professionals in the major capital cities of Asia. Our mission is to provide a stable, reliable local platform so that our clients can grow their sales in challenging Asian markets.

.

Blog Posts

Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Read more
Thai FDA Documentation Exemptions for Concise and Full Regulatory Pathways

Thai FDA Regulatory Documentation Exemptions

March 12, 2024: the Thai FDA released draft guidance updating the list of required documentation for Full and Concise Evaluation. For manufacturers registering a medical device in Thailand, certain documents are no longer required.
Read more
Hong Kong MDD adds Singapore HSA to Reference Country List

Hong Kong MDD Adds Singapore as Reference Country

Starting April 2nd, 2024, the Hong Kong Medical Device Division (MDD) accepts, on a regular basis, the marketing approvals obtained from the the Health Sciences Authority (HSA) of Singapore as a support of compliance of medical device to the "Essential Principles of Safety and Performance of Medical Devices" (Technical Reference: TR-004) under MDACS.
Read more